B lymphocytes
or B cells and T lymphocytes or T cells are the major players in adaptive
immune response. T cells mediate cell mediated immunity whereas B cells are
behind antibody mediated or humoral immunity. They possess antigen binding cell
surface receptors responsible for specificity, diversity memory and
self/non-self recognition by the immune system.
See the Difference between B cells and T cells
See the Difference between B cells and T cells
B cells originate and mature in
bone marrow itself. Two major functions of B cells are
- they differentiate into plasma cells that produce antibodies; and memory B cells that is responsible for immunologic memory
- B cells acts as antigen presenting cells (APCs)
B cells
|
Plasma cells
|
B Cells possess a surface B Cell receptor (BCR) composed
of surface immunoglobulin (Ig) for antigen binding and a transmembrane
protein made up of two heterodimer subunits of Ig-α and Ig-β called as CD79 for signal transduction
|
Plasma cells lacks surface receptors like BCR
|
B cells are formed from hoematopoetic stem cells of
bone marrow
|
Plasma cells are formed by the differentiation of B
cells upon activation
|
Naive B cells do not secrete antibodies
|
High rate of secretion of antibodies by plasma cells
|
B Cells has MHC class II receptor as it functions as
antigen presenting cells (APC)
|
Mature plasma cells lacks MHC class II receptor
|
Common mature B cell markers are CD19, CD 20, CD21,
CD22
|
Plasma cells often express Syndecan1 (CD138), CD44
and VLA-4 on their surface (common markers)
|
B cells in peripheral lymphoid tissue are
predominantly long-lived, with a life span of between 4 and 7 weeks
|
Plasma cells may be short‐lived, surviving only 3–5
days often found in the secondary lymphoid tissue. Generally, these secrete
lower affinity antibody. Alternatively, plasma cells may be long‐lived,
surviving decades or the lifetime of an animal, secreting high‐affinity
antibody majority of which found in the bone marrow
|
*Antibody class switching and somatic hypermutation occurs
in mature B cells in response to antigen stimulation and costimulatory
signals.
|
No such mechanisms reported so far in plasma cells
|
Reference
Wang, K.,
Wei, G., & Liu, D. (2012). CD19: a biomarker for B cell development,
lymphoma diagnosis and therapy. Experimental hematology & oncology, 1(1),
36.
Post a Comment
We Love to hear from U :) Leave us a Comment to improve this site
Thanks for Visiting.....